MRD / Regn No. : 20250000063 Date : 01/07/2026
Patient Name : Subhikshaa DP Age & Gender : 17 Yrs. / Female
Contact No. : 9345622179 UHID :
Ht / Wt / BMI : 154 / 55 / 23.19 BP S / BP D : /
Allergies : NKA Referred By :
   
Subjective : DR GAYATRI,DM DIAGNOSED 1 YEARS,ON 5 MG BID,DIETARY INDISCRETION,RARE HYPOGLYCEMIA,MENSES RESUMED
Objective : NONE
Analysis : DIABETES MELLITUS,ANTI GAD NEGATIVE,REASONABLE BETA CELL RESERVE,NO DETECTABLE MUTATIONS ON COMMERCIAL MODY SCREEN,GLUCOSE BETTER,MILD TSH ELEVATION
Plan : CONTINUE CURRENT MEDICATIONS,CLINICAL FOLLOW UP,SEE ME IN 2 MONTHS WITH TESTING  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 74 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 6.1 % | POST PRANDIAL GLUCOSE (2HPP): 88 mg/dL | TOTAL T3: 1.35 | TOTAL T4: 9.36 mcg/dL | TSH : 6.24 mIU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 GLIBENCLAMIDE 5 MG
DAONIL 5 MG 		1-0-1 BEFORE FOOD
 TILL NEXT VISIT
2 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES 		SQ 10-0-6 UNITS BEFORE FOOD
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
       
Refill : 0 / Substitution:    
Education :
Next Visit : 30/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP SMBG
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: